Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Raw Materials (2019 - 2025)

CorMedix's Raw Materials history spans 4 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, Raw Materials rose 227.18% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, up 227.18%, while the annual FY2025 figure was $3.6 million, 227.18% up from the prior year.
  • Raw Materials for Q4 2025 was $3.6 million at CorMedix, down from $7.0 million in the prior quarter.
  • Across five years, Raw Materials topped out at $7.0 million in Q3 2025 and bottomed at $603545.0 in Q3 2024.